Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment completed in STELLAR 3 pivotal trial of Xyotax

Dec. 1, 2003

Antiangiogenic and antiproliferative effects described for AP-23573 in tumor cells

Dec. 1, 2003

Plenaxis receives FDA approval

Nov. 28, 2003

Introgen and SWOG to evaluate Advexin plus surgery in phase II trial

Nov. 28, 2003

Antisoma and EMD Lexigen create immunocytokine fusion protein

Nov. 28, 2003

Preliminary phase I results on EKB-569 for advanced colorectal cancer

Nov. 28, 2003

ET-743 is associated with changes in the gene expression of sarcoma cells

Nov. 28, 2003

Metvix approved in Switzerland

Nov. 27, 2003

Novel EGFR inhibitors under study at Boehringer Ingelheim

Nov. 27, 2003

Japanese researchers describe protein kinase inhibitors as antineoplastic enhancing agents

Nov. 27, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.